| Outcome Measures: |
Primary: End stage kidney disease, The primary endpoint is a time to event outcome, considering the following composite endpoint: * End stage kidney disease * eGFR decline of at least 40% * Cardiovascular events among myocardial infarction, heart failure, hospitalization and stroke * All cause mortality, Up to 36 months|eGFR decline of at least 40%, The primary endpoint is a time to event outcome, considering the following composite endpoint: * End stage kidney disease * eGFR decline of at least 40% * Cardiovascular events among myocardial infarction, heart failure, hospitalization and stroke * All cause mortality, Up to 36 months|Cardiovascular events, The primary endpoint is a time to event outcome, considering the following composite endpoint: * End stage kidney disease * eGFR decline of at least 40% * Cardiovascular events among myocardial infarction, heart failure, hospitalization and stroke * All cause mortality, Up to 36 months|All cause mortality, The primary endpoint is a time to event outcome, considering the following composite endpoint: * End stage kidney disease * eGFR decline of at least 40% * Cardiovascular events among myocardial infarction, heart failure, hospitalization and stroke * All cause mortality, Up to 36 months | Secondary: Time to end-stage kidney disease, All components of the composite endpoint will be assessed separately, Up to 36 months|Time to eGFR decrease of at leat 40%, All components of the composite endpoint will be assessed separately, Up to 36 months|Time to the first cardiovascular event among myocardial infarction, heart failure, hospitalization and stroke, All components of the composite endpoint will be assessed separately, Up to 36 months|All-cause mortality, All components of the composite endpoint will be assessed separately, Up to 36 months|Change from baseline in blood pressure, Systolic and diastolic blood pressure at months 3 and 6 then every 6 months (home blood pressure monitoring and office blood pressure measurement),, From baseline and up to 36 months|Proportion of patients with controlled blood pressure, Proportion of patients with controlled blood pressure at 2 years (PA\< 135/85mmHg with home blood pressure monitoring), 24 months|Change from baseline in glomerular filtration rate, Change from baseline in glomerular filtration rate estimated by CKD-EPI formula at months 3 and 6 then every 6 months, From baseline and up to 36 months|Change from baseline in proteinuria (g/d) or proteinuria /creatinuria (g/g), Change from baseline in proteinuria (g/d) or proteinuria /creatinuria (g/g) at months 3 and 6 then every 6 months, From baseline and up to 36 months|Proportion of patients who used at least one diuretic, Up to 36 months|Change from baseline in quality of life, Change from baseline in quality of life assessed by PROMIS-29 survey each year, From baseline and up to 36 months
|
| Locations: |
Department of Nephrology, University Hospital of Angers, Angers, 49933, France|Department of Nephrology, University Hospital of Bordeaux, Bordeaux, 33000, France|AUB Santé foundation, Brest, Brest, 29200, France|Department of Nephrology, University Hospital of Brest, Brest, 29200, France|Department of Nephrology, Hospital of Chalon-sur-Saône, Chalon-sur-Saône, France|Department of Nephrology, Hospital of Chartres, Chartres, 28630, France|Department of Nephrology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, 63001, France|Department of Nephrology, Hospital of Colmar, Colmar, 68024, France|Department of Nephrology, University Hospital of Grenoble, Grenoble, 38043, France|Department of Nephrology, Hospital of Haguenau, Haguenau, 67500, France|Department of Nephrology, Departemental Hospital of Vendée, La Roche-sur-Yon, 85925, France|ECHO Santé Association, Le Mans, Le Mans, 72100, France|Department of Nephrology, Hospital of Le Puy en Velay, Le Puy-en-Velay, 43012, France|Department of Nephrology, University Hospital of Limoges, Limoges, 87042, France|Department of Nephrology, University Hospital of Lyon, Lyon, 69003, France|Department of Nephrology, University Hospital of Marseille, Marseille, 13005, France|Department of Nephrology, Regional Hospital of Metz, Metz, 57085, France|Department of Nephrology, Régional Hospital of Mulhouse, Mulhouse, 68100, France|Department of Nephrology, University Hospital of Nantes, Nantes, 44093, France|ECHO Santé Association, Nantes, Nantes, 44402, France|Department of Nephrology, University Hospital of Nîmes, Nîmes, 30029, France|Department of Nephrology, European Hospital Georges Pompidou, AP-HP, Paris, 75015, France|Department of Nephrology, Necker Hospital, AP-HP, Paris, 75015, France|Department of Nephrology, Bichat Hospital, AP-HP, Paris, 75018, France|Department of Nephrology, Tenon Hospital, AP-HP, Paris, 75020, France|Department of Nephrology, Hospital of Perpignan, Perpignan, 66046, France|Department of Nephrology, University Hospital of Reims, Reims, 51092, France|Department of Nephrology, University Hospital of Rennes, Rennes, 35033, France|Department of Nephrology, Hospital of Roubaix, Roubaix, 59100, France|Department of Nephrology, University Hospital of Rouen, Rouen, 76230, France|ECHO Santé Association, Saint Herblain, Saint-Herblain, 44819, France|Department of Nephrology, Hospital of Saint Malo, Saint-Malo, 35400, France|Department of Nephrology, University Hospital of Saint Etienne, Saint-Étienne, 42270, France|Department of Nephrology, University Hospital of Tours, Tours, 37044, France|Department of Nephrology, Hospital of Valenciennes, Valenciennes, 59322, France|Department of Nephrology, University Hospital of Nancy, vandoeuvre les Nancy, 54511, France
|
